Protocol for the FibroCAN study: a randomised controlled trial of finerenone treatment for early-stage cardiovascular autonomic neuropathy in type 2 diabetes
ClinicalTrials.gov: NCT06906081; registration date: 25 March 2025. Clinical Trials Information System: EUCT no. 2024-516597-30-00; registration date: 3 September 2024.
Authors
- Maria Bitsch Poulsen (ORCID: https://orcid.org/0000-0001-5747-2584)
- Tarunveer S. Ahluwalia (ORCID: https://orcid.org/0000-0002-7464-3354)
- Christina Brock (ORCID: https://orcid.org/0000-0002-3381-1884)
- Jens Hove Buciek (ORCID: https://orcid.org/0000-0003-3549-7689)
- Christian Stevns Hansen (ORCID: https://orcid.org/0000-0002-5782-3476)
- Asbjørn Mohr Drewes (ORCID: https://orcid.org/0000-0001-7465-964X)
- Birgitte Brock (ORCID: https://orcid.org/0000-0002-1598-6023)
- Páll Karlsson (ORCID: https://orcid.org/0000-0001-7082-9576)
- Peter R Rossing (ORCID: https://orcid.org/0000-0002-1531-4294)
- Tina Okdahl (ORCID: https://orcid.org/0000-0003-2659-4313)
Institutions
- Roskilde University (DK)
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Aarhus University (DK)
- Aalborg University Hospital (DK)
- Aarhus University Hospital (DK)
- Danish Pain Research Center (DK)
- Aalborg University (DK)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/bmjopen-2025-101074
- Primary Topic
- Heart Rate Variability and Autonomic Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Vissing Fonden
- Novo Nordisk
- Svend Andersen Fonden
- Novo Nordisk Fonden